Identifier
Created
Classification
Origin
09STOCKHOLM769
2009-12-11 07:54:00
UNCLASSIFIED
Embassy Stockholm
Cable title:
SWEDEN'S RESPONSE TO CYSTIC FIBROSIS STUDY PROPOSAL
how-toVZCZCXYZ0100 RR RUEHWEB DE RUEHSM #0769 3450754 ZNR UUUUU ZZH R 110754Z DEC 09 FM AMEMBASSY STOCKHOLM TO SECSTATE WASHDC 4975
UNCLAS STOCKHOLM 000769
SIPDIS
STATE FOR FDA DAVID KELLY
E.O. 12958: N/A
TAGS: KSCA OSCI ABUD AFIN TBIO SW
SUBJECT: SWEDEN'S RESPONSE TO CYSTIC FIBROSIS STUDY PROPOSAL
REF: STATE 121848
Post provided reftel to Dr. J. Todd Weber, CDC Liaison at the
European Center for Disease Prevention and Control in
Stockholm, for review and recommendation. Weber replied that
the proposal, which he noted had already been approved by
Institutional Review Boards at all participating countries,
"is clearly a legitimate drug/chemical to be studying at the
Phase III stage." Post does not forsee any foreign policy
implications for the study.
BARZUN
SIPDIS
STATE FOR FDA DAVID KELLY
E.O. 12958: N/A
TAGS: KSCA OSCI ABUD AFIN TBIO SW
SUBJECT: SWEDEN'S RESPONSE TO CYSTIC FIBROSIS STUDY PROPOSAL
REF: STATE 121848
Post provided reftel to Dr. J. Todd Weber, CDC Liaison at the
European Center for Disease Prevention and Control in
Stockholm, for review and recommendation. Weber replied that
the proposal, which he noted had already been approved by
Institutional Review Boards at all participating countries,
"is clearly a legitimate drug/chemical to be studying at the
Phase III stage." Post does not forsee any foreign policy
implications for the study.
BARZUN